home All News open_in_new Full Article

Novo Nordisk se dispara en bolsa tras aprobar EEUU un uso adicional para Wegovy y bajar el precio de Ozempic

Los pacientes sin seguro de Estados Unidos pagaban el medicamento por 1.000 dólares al mes. Ahora, 499. Leer


today 57 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Society
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 3711859338
Add Watch Country

arrow_drop_down